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To elucidate the molecular mechanisms controlling the expression of the hypha-specific adhesin gene
HWP1 of Candida albicans, its promoter was dissected and analyzed using a green fluorescent protein
reporter gene. A 368-bp region, the HWP1 control region (HCR), was critical for activation under
hypha-inducing conditions and conferred developmental regulation to a heterologous ENO1 promoter. A
more distal region of the promoter served to amplify the level of promoter activation. Using gel mobility
shift assays, a 249-bp subregion of HCR, HCRa, was found to bind at least four proteins from crude
extracts of yeasts and hyphae with differing binding patterns dependent on cell morphology. Four proteins
with DNA binding activities were identified by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis after separation by anion-exchange and heparin-Sepharose chromatography. One protein with
high similarity to Nhp6, an HMG1 family member in Saccharomyces cerevisiae, and another with weak
similarity to an HMG-like condensation factor from Physarum polycephalum implicated changes in chromatin structure as a critical process in hypha-specific gene regulation. Proteins with strong homology to
histones were also found. These studies are the first to identify proteins that bind to a DNA segment that
confers developmental gene regulation in C. albicans and suggest a new model for hypha-specific gene
regulation.

Candida albicans is an opportunistic fungal pathogen that
rapidly transitions between yeast, true hyphal, and pseudohyphal growth forms in response to a number of environmental
stimuli, including temperature, pH, and medium composition
(15, 19, 21). Changes in the external environment of C. albicans
are known to be accompanied by changes in the genetic expression patterns of morphology-specific transcripts, leading in
turn to the activation and deactivation of genetic pathways that
are believed to underlie the multiple interactions of C. albicans
with its mammalian hosts, including the colonization and invasion of tissue and resistance to host defenses (16, 28).
The true hyphal morphology of C. albicans (43) is notable
for its enhanced adherence in comparison to yeast forms (40),
and this is reflected in the presence of hypha-specific proteins
that promote the invasion of and adherence to host surfaces.
One such protein, Hwp1 (hyphal wall protein 1), is a glycosylphosphatidylinositol-linked cell wall protein that is abundantly expressed when C. albicans is in hyphal growth mode
and is absent or barely detectable in the yeast morphology (41).
Hwp1 is incorporated into the cell wall at the tips of apically
growing hyphae, limiting its presence to hyphal surfaces (39).

Hwp1 has been shown to play a key role in the attachment of
C. albicans to human buccal epithelial cells by forming covalent
bonds through its function as a substrate for epithelial transglutaminases (40). HWP1 gene expression is regulated at the
level of mRNA. Northern blot analysis reveals abundant
steady-state levels of HWP1 mRNA during hyphal growth but
not yeast growth (41). Under hypha-inducing conditions,
HWP1 mRNA becomes detectable within 15 min and increases
over a period of several hours (3).
The regulation of HWP1 expression is believed to be intimately associated with a number of protein factors that themselves play key roles in the yeast-to-hypha transition. This has
been shown in a variety of studies using mutants that exhibit
both aberrant yeast-hypha transitions and altered HWP1 expression patterns. Those studies implicated the cyclic AMP
signaling pathway and Efg1, a downstream transcription factor
of this pathway, in both processes (4, 42). A number of additional contributors to HWP1 expression have also been uncovered, including the activators Cph2 and Tec1 (23, 37), the
repressors Tup1 and Nrg1 (6, 27), and the biofilm factor Bcr1
(30). However, little has been done to explore the regulation of
hypha-specific genes like HWP1 at the level of the promoter. It
remains unclear whether the effect of these and other regulatory factors on HWP1 expression is the result of a direct interaction with promoter sequences or is instead an indirect effect
of a morphogenesis regulatory pathway.
In previous work, we found that the 1,410 bp immediately
upstream of the transcription start site of HWP1 conferred
successful developmental regulation to a green fluorescent
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protein (GFP) reporter (39). However, additional analyses
have revealed that the HWP1 promoter extends further upstream and is more complex than previously thought, necessitating the inclusion of additional DNA in the reporter plasmid.
Here, we report an extensive dissection of the HWP1 promoter
that unveiled a particular region, HCR, that is critical for
activation and is able to confer developmental regulation on a
heterologous promoter. Different sets of HCR/DNA binding
protein interactions from crude extracts of yeast and hyphal
cells were observed, four such proteins were isolated and identified, and their binding to a subregion of HCR was confirmed
by the use of recombinant proteins. To our knowledge, these
studies are the first to identify proteins from C. albicans that
bind to a promoter region shown to confer developmental
regulation to a hypha-specific gene. The results form the basis
for a new model of hypha-specific gene regulation in C. albicans.
MATERIALS AND METHODS
Strains and growth conditions. A complete list of strains is shown in Table 1.
C. albicans strains were stored at ⫺80°C prior to use. Strain CAI4 (12) was the
parent strain for the preparation of the GFP reporter strains. Selection of Ura⫹
CAI4 transformants containing promoter deletion plasmids was performed on
yeast nitrogen base (YNB) plates supplemented with 50 mM glucose. C. albicans
SC5314 served as the source of crude extract preparations for HWP1 control
region a (HCRa) protein binding assays and was plated onto yeast-peptonedextrose plates supplemented with 20 g/ml uridine at 30°C prior to use. For
GFP reporter assays, yeast strains grown for 48 h to stationary phase in liquid
YNB medium at 30°C and 250 rpm were used to inoculate medium 199 (Invitrogen, Carlsbad, CA), yeast-peptone-dextrose with 10% bovine calf serum (7), or
modified Lee’s medium (pH 6.8) (8) at a concentration of 5 ⫻ 106 cells/ml. The
cells were allowed to germinate at 37°C for 2.5 h at 100 rpm unless otherwise
indicated.
Luria broth (LB) or agar was used for the growth of Escherichia coli strains,
and RM base medium (in grams per liter: Casamino Acids, 20.0; KH2PO4, 3.0;
NaCl, 0.5; Na2HPO4, 6.0; NH4Cl, 1.0; MgCl2, 0.095; pH 7.0) containing 0.2%
glucose was used for protein expression experiments. E. coli TOP10 (Invitrogen,
Carlsbad, CA) and DH5␣ competent cells used for cloning were grown, where
appropriate, in the presence of LB plus 100 g/ml ampicillin, 25 g/ml kanamycin, or 50 g/ml zeomycin for plasmid selection and maintenance.
Plasmid construction. (i) GFP reporter plasmids. Plasmid pHWP1GFP3,
which contains 1,410 bp of upstream sequence from the HWP1 transcription start
site, was previously described (39). Additional HWP1 DNA upstream of position
⫺1410 was obtained using Lambda 1, a clone from a C. albicans genomic library
containing HWP1 (31). Plasmid pBSRI 1.9-16 was created by cloning an 11.9-kb
Lambda 1 EcoRI fragment that overlapped the HWP1 promoter region found in
pHWP1GFP3 into pBluescript SK(⫺). DNA regions from position ⫺2025 or from
position ⫺1902 to the BamHI site at position ⫺444 were amplified by PCR using
primers that engineered XhoI sites at the 5⬘ ends (see Table 2 for primer sequences).
PCR products and pHWP1GFP3 were digested with XhoI and BamHI and ligated
together to create plasmids p1902.GFP3 and pHWP1.2025GFP3.
(ii) Plasmids containing promoter deletions. External deletions upstream of
position ⫺1410 were generated using pBSRI-1.9-16 as a PCR template to amplify regions between the desired 5⬘ end and the native BamHI site at position
⫺444. PCR products and pHWP1GFP3 were digested with XhoI and BamHI
and incubated with T4 DNA ligase (Invitrogen, Carlsbad, CA) to create plasmids
p1782, p1657, and p1535 (Table 1). External deletions downstream of position
⫺1410 were created by using pBSBglII1.8 (39) as a template in PCR to amplify
regions between the desired 5⬘ and 3⬘ ends using primers to engineer HindIII and
XhoI sites on the 3⬘ and 5⬘ ends of the PCR products, respectively. These
products and pHWP1GFP3 were digested with XhoI and HindIII and incubated
with T4 DNA ligase to create plasmids p1242, p1209, p1153, p1063, p831, p803,
p555, and p140.
Internal deletion S was created by PCR-ligation-PCR (1, 2). The HWP1 promoter regions at positions ⫺1902 to ⫺1410 and ⫺1042 to ⫹60 were PCR
amplified with a genomic DNA template using primer pairs TX1902/B1411 and
T1042/H39, respectively, whereas the resultant PCR products served as a template for the second reaction with primers TX1902 and H39. The final PCR
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product was digested with XhoI and HindIII and cloned into pHWP1GFP3 to
create pSGFP3.
Internal HWP1 promoter deletions E, M, and K2 were cloned by amplifying
the ⫺1902 to ⫺1657, ⫺1410 to ⫺1042, or ⫺1288 to ⫺1042 region, respectively,
and engineering XhoI ends by PCR with a genomic DNA template. The resulting
products were ligated into p856GFP3, which contains external deletion ⫺555, to
create plasmids pEGFP3, pK2GFP3, and pMGFP3.
To test that the activating ability of the 368-bp HCR segment was not the
result of spatial effects, 376 bp of DNA from the enolase coding region was
cloned into plasmid pSGFP3 to replace HCR. A unique EcoRV restriction site
was placed at position ⫺1042 in plasmid pSGFP3 using the QuikChange sitedirected mutagenesis kit (Stratagene, La Jolla, CA). Primer set E15 was used to
amplify the replacement DNA, adding EcoRV restriction sites to either end
(Table 2). The pSGFP3 site-directed mutagenesis product and the E15 PCR
product were digested with EcoRV, purified, and ligated to create plasmid
pSENO1.
To test whether HCR could activate a different promoter, a basal promoter
was created using pENO1GFP3 (39). A unique EcoRV site 20 bp upstream from
the enolase promoter TATA box was added by site-directed mutagenesis as
described above. The resulting plasmid was digested with EcoRV and XhoI to
remove the activating regions of the enolase promoter and purified by gel
extraction (QIAGEN, Valencia, CA). Primer set HCR was used for PCR with
the genomic DNA template to generate the HCR fragment from the HWP1
promoter with engineered XhoI and EcoRV sites. The resulting PCR product
and pENO1GFP3 were digested with XhoI and EcoRV and ligated to create
plasmid pEX-1.
(iii) Plasmids containing putative HCRa binding protein transcripts. A
249-bp PCR fragment encompassing positions ⫺1410 to ⫺1162 and named
HCRa was amplified using primer set TR06 with genomic DNA as a template.
The HCRa PCR product was cloned into pCR4-TOPO to create pSKD19. The
C. albicans NHP6 gene with an N-terminal His6 tag was amplified by PCR using
primers NHP-h6 Xho and NHP Spe with genomic DNA as a template. The PCR
product was digested with SpeI and XhoI and ligated into pPICZ␣C (Invitrogen,
Carlsbad, CA) with digested XbaI and XhoI sites to create pSKD306. To generate pSKD703, which was engineered to have a His6 tag at its N terminus,
His6-Nhp6 was PCR amplified from pSKD306 using primers NHP6-h6 and NHP
Spe and cloned into pBAD202/D-TOPO (Invitrogen, Carlsbad, CA).
C. albicans GCF1, HTB1, and HTA1 were amplified with primer sets GCF1,
HTB1, and HTA1, respectively. The resultant PCR products were cloned into
the pBAD202/D-TOPO vector to generate plasmids pSKD710, pSKD721, and
pSKD723 that placed sequences encoding thioredoxin and a His6 tag on their N
and C termini, respectively.
All plasmid constructs were sequenced to verify accuracy.
Strain construction. (i) Integration of pHWPGFP3 at the HWP1 locus. To
create a C. albicans strain with GFP at the native HWP1 locus, pHWP1GFP3 was
linearized at its unique BamHI site and transformed by the spheroplast method
(20) into CAI4, creating strain HB-12. Genomic DNA was digested with BglII
and probed with a fragment spanning HWP1 promoter positions ⫺1063 to ⫹7 to
verify low-copy integration by Southern blotting (not shown).
(ii) Integration of HWP1 promoter deletion plasmids at the ENO1 locus.
ClaI-digested plasmid DNA from each promoter deletion construct was transformed into C. albicans CAI4 as described above. For each construct, multiple
independent transformants were analyzed by Southern blotting as previously
described (39).
(iii) Preparation of crude extracts. Crude extracts from stationary-phase yeast
were prepared from cultures grown for 48 h in YNB medium supplemented with
2% glucose and 120 g/liter of appropriate nutrients. Crude extracts from hyphae
and yeast were prepared as described above except that cells were incubated for
1 h. To ensure that cells were uniformly destined to become true hyphae (⬎95%)
or budding yeast, an aliquot from each culture was incubated for 3 h, and cell
morphologies were verified microscopically. Cultures were collected by centrifugation at 4,000 rpm for 20 min and resuspended in breakage buffer [180 mM
Tris-HCl (pH 7.5), 350 mM (NH4)2SO4, 10 mM MgCl2, 1 mM EDTA, 10%
(vol/vol) glycerol, 7 mM ␤-mercaptoethanol, 1⫻ protease inhibitor cocktail, 1
mM phenylmethylsulfonyl fluoride]. The cells were disrupted by three passages
through a French press (20,000 lb/in2 [1 lb/in2 ⫽ 6.9 kPa]) and then bead beaten
at 4,200 rpm and 20 s for seven cycles. The crude extract was then centrifuged at
10,000 ⫻ g for 2 min to remove unbroken cells and ultracentrifuged at 150,000 ⫻ g
for 2 h at 4°C. The recovered extracts were dialyzed against buffer A (20 mM
Tris-HCl [pH 8.0], 50 mM NaCl, 10 mM MgCl2, 1 mM dithiothreitol, 0.5 mM
EDTA, 5% glycerol).
Analysis of crude cell extracts. (i) Anion-exchange column chromatography.
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TABLE 1. Strains and plasmids
Strain or plasmid

Reference or
source

Genotype or description

Strains
SC5314
CAI4
HB-12
EGFP3
⫺2025
⫺1902
⫺1782
⫺1657
⫺1535
HGFP3(⫺1410)
⫺1366
⫺1242
⫺1209
⫺1153
⫺1063
⫺831
⫺803
⫺555
⫺140
E
K2
M
S
HCRENO
SENO

Wild type
⌬ura3::imm434/⌬ura3::imm434
As CAI4 but with plasmid pHWP1GFP3 integrated at the HWP1 locus
As CAI4 but with plasmid pENO1GFP3 integrated at the ENO1 locus
As CAI4 but with plasmid p2025 integrated at the ENO1 locus
As CAI4 but with plasmid p1902 integrated at the ENO1 locus
As CAI4 but with plasmid p1782 integrated at the ENO1 locus
As CAI4 but with plasmid p1657 integrated at the ENO1 locus
As CAI4 but with plasmid p1535 integrated at the ENO1 locus
As CAI4 but with plasmid pHWP1GFP3 integrated at the ENO1 locus
As CAI4 but with plasmid p1366 integrated at the ENO1 locus
As CAI4 but with plasmid p1242 integrated at the ENO1 locus
As CAI4 but with plasmid p1209 integrated at the ENO1 locus
As CAI4 but with plasmid p1153 integrated at the ENO1 locus
As CAI4 but with plasmid p1063 integrated at the ENO1 locus
As CAI4 but with plasmid p831 integrated at the ENO1 locus
As CAI4 but with plasmid p803 integrated at the ENO1 locus
As CAI4 but with plasmid p555 integrated at the ENO1 locus
As CAI4 but with plasmid p140 integrated at the ENO1 locus
As CAI4 but with plasmid pEGFP3 integrated at the ENO1 locus
As CAI4 but with plasmid pK2GFP3 integrated at the ENO1 locus
As CAI4 but with plasmid pMGFP3 integrated at the ENO1 locus
As CAI4 but with plasmid pSGFP3 integrated at the ENO1 locus
As CAI4 but with plasmid pEX-1 integrated at the ENO1 locus
As CAI4 but with plasmid pSENO1 integrated at the ENO1 locus

14
12
This
39
This
This
This
This
This
39
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This

Plasmids
pCR4-TOPO

Kanr Ampr lacZ␣; maintenance of PCR products

Invitrogen,
Carlsbad, CA
Invitrogen,
Carlsbad, CA
Invitrogen,
Carlsbad, CA
39
39
39
This study

pPICZ␣C

Zeor; protein expression in Pichia pastoris

pBAD202/D-TOPO

Kanr; protein expression in E. coli

pHWP1GFP3
pENO1
pENO1GFP3
pBSRI 1.9-16

pBluescript SK(⫺) with 1,410 bp upstream of HWP1 driving GFP expression
pBluescript SK(⫺) with full ENO1 open reading frame
pBluescript SK(⫺) with full ENO1 promoter driving GFP expression
pBluescript SK(⫺) with 11.9-kb EcoRI C. albicans genomic clone encompassing
HWP1 promoter
pBluescript SK(⫺) with 1.8-kb BglII C. albicans genomic clone encompassing
HWP1 positions ⫺1410–⫹6020
pBluescript SK(⫺) with 1,902 bp upstream of HWP1 driving GFP expression
pBluescript SK(⫺) with 2,025 bp upstream of HWP1 driving GFP expression
pHWP1GFP3 with HWP1 promoter positions ⫺1782–⫹60
pHWP1GFP3 with HWP1 promoter positions ⫺1657–⫹60
pHWP1GFP3 with HWP1 promoter positions ⫺1535–⫹60
pHWP1GFP3 with HWP1 promoter positions ⫺1366–⫹60
pHWP1GFP3 with HWP1 promoter positions ⫺1242–⫹60
pHWP1GFP3 with HWP1 promoter positions ⫺1209–⫹60
pHWP1GFP3 with HWP1 promoter positions ⫺1153–⫹60
pHWP1GFP3 with HWP1 promoter positions ⫺1063–⫹60
pHWP1GFP3 with HWP1 promoter positions ⫺831–⫹60
pHWP1GFP3 with HWP1 promoter positions ⫺803–⫹60
pHWP1GFP3 with HWP1 promoter positions ⫺555–⫹60
pHWP1GFP3 with HWP1 promoter positions ⫺140–⫹60
pHWP1GFP3 with HWP1 promoter positions ⫺1410–⫺1042, ⫺555–⫹60
pHWP1GFP3 with HWP1 promoter positions ⫺1288–⫺1042, ⫺555–⫹60
pHWP1GFP3 with HWP1 promoter positions ⫺1902–⫺1657, ⫺555–⫹60
pHWP1GFP3 with HWP1 promoter positions ⫺1902–⫺1410, ⫺1042–⫹60
pSGFP3 with HWP1 promoter positions ⫺1410–⫺1042 replaced with 376 bp of
ENO1 coding region
pENO1GFP3 with ENO1 promoter replaced by HWP1 promoter ⫺1410–⫺1042
pCR4-TOPO with HWP1 promoter positions ⫺1410–⫺1162
pPICZ␣C with N-terminal His6-tagged NHP6
pBAD202/D-TOPO with N-terminal His6-tagged NHP6
pBAD202/D-TOPO with GCF1 without stop codon
pBAD202/D-TOPO with HTB1 without stop codon
pBAD202/D-TOPO with HTA1 without stop codon

pBSBglII1.8
p1902.GFP3
pHWP1.2025GFP3
p1782
p1657
p1535
p1366
p1242
p1209
p1153
p1063
p831
p803
p555
p140
pEGFP3
pK2GFP3
pMGFP3
pSGFP3
pSENO1
pEX-1
pSKD19
pSKD306
pSKD703
pSKD710
pSKD721
pSKD723

study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study

39
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This

study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study

This
This
This
This
This
This
This

study
study
study
study
study
study
study
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TABLE 2. Oligonucleotidesa

Oligonucleotide

Construct(s)

External deletions
TX2025
TX1902
TX1840
TX1782
TX1657
TX1535
X2
T1365
T1288
T1241
T1208
X259
X348
X580
X608
X856
X1271
B425
H39

⫺2025
⫺1902
⫺1840
⫺1782
⫺1657
⫺1535
⫺1410
⫺1366
⫺1289
⫺1242
⫺1209
⫺1153
⫺1063
⫺831
⫺803
⫺555
⫺140
External
External

GGCCTCGAGAATTATCGGGTGATTAATAACATGC
GGCCTCGAGGGTAATTATTGGAATGAACGTG
GCCTCGAGACTAAATAGGTAATTGTTTATTTTTAGC
GGCCTCGAGCTAATGATTGTGACTATTGAAAATG
GGCCTCGAGTGGGTCTAGTAATGTTGTGC
GGCCTCGAGGTAAACAAACTCCCACAACCAATCG
GGCTCGAGGATCTTTCTTTTTCATTTCCC
CCGCTCGAGGTGGAAATAAAGCTATGATAAATG
CCGCTCGAGTGTTGTTGTCCTCGTCTCG
CCGCTCGAGCAAGAAATACAGGAAACCCTCC
CCGCTCGAGTTTGGACCTTACACGCAC
GGCTCGAGGAAACATACGATATGTTATTCTTT
GGCTCGAGGGTAAGAGTTGCCTAACCATTG
GGCTCGAGCCACTAATTCCATCAATAAAAT
GGCTCGAGGTGTATTGTTCTCTTCAGTACATT
GGCTCGAGCTCGACTAATCGACTTTACATCAA
GGCTCGAGCATAGCAACTCTTGTAAAGTC
GAATTCCTTGTTTTTGGATCCAAAG
GGAAGCTTATTGACGAAACTAAAAGCG

XhoI
XhoI
XhoI
XhoI
XhoI
XhoI
XhoI
XhoI
XhoI
XhoI
XhoI
XhoI
XhoI
XhoI
XhoI
XhoI
XhoI
EcoRI, BamHI
HindIII

Internal deletions
BX1042
BX1289
BX1657
T1042
B1411

E, K2
K2
M
S
S

GGCCTCGAGCAATGGTTAGGCAACTCTTACC
GGCCTCGAGACGTACTTTTTAACTGTCAAACGTG
CCGCTCGAGAGCTAAGAGTTTTTTATGGCATTC
GAAAATAATAGGCTAAGGTTTTTCCTGATGCG
CTTTATATGCTAGCAATAAAGTCAAAGAACAAGG

XhoI

GGAGATATCGATTGACCGTATTTCTTC
GGCGATATCTTGTCGACCAAGCTAAGATT
GGGCTCGAGAGATCTTTCTTTTTCATTTCCCTTAAAACCGA
TCAA
GGGGATATCAGATGGTTAGGCAACTCTTACCTTTTCATTTCC
AGATCTTTCTTTTTCATTTCCCTT
TATTATGGCAAGTTTATCCGCAAT
AAAACTCGAGATGCATCATCATCATCATCATGCTCCAGGTGA
AAGAAAGAAGTCC
CACCATGCATCATCATCATCATCATGCTCCAGG
AAAAACTAGTTAGGCGGAATTCTTTTTAGCGTATTCAGCC
CACCATGTTGAGATCATTTGTAACATCTATTAGTCC
AAAGTCATCCTCCACTTTGTAGTTTTCC
CACCATGGCCCCAAAAGCAGAAAAGAAACCAGC
ACTAGAAGCAGATGAGTATTTTGTGACG
CACCATGTCAGGTGGTAAAGGTAAAGCAGGAACTTCC
CAATTCTTGAGAAGCCTTAACACCACC
TTGTGGGCCAGACAACCATTTAG
CCAAAACGTTTTGAACGGTGGTTCC

EcoRV
EcoRV
XhoI

Other constructs
E15 for
E15 rev
HCR for
HCR rev
TRO6 for
TRO6 rev
NHP-h6 Xho
NHP-h6
NHP Spe
mtHMG for
mtHMG rev
HTB1 for
HTB1 rev
HTA1for
HTA1 rev
ENO2 for
ENO2 rev
a

Sequence (5⬘–3⬘)

Site(s) added

XhoI

EcoRV
XhoI, His6 tag
His6 tag
SpeI

Underlining, primary engineered restriction site; boldface type, additional engineered restriction site or His, tag.

To investigate the potential differences in DNA binding activities in the three
growth conditions, crude hyphal, yeast, and stationary-phase yeast extracts were
loaded onto a 1-ml HiTrap Q-Sepharose Fast Flow column (strong anion) (GE
Healthcare, Piscataway, NJ) according to the manufacturer’s instructions. A
stepwise elution of proteins was carried out using increasing concentrations of
NaCl (0.2, 0.3, 0.4, 0.5, and 1.0 M) in buffer A.
(ii) Ammonium sulfate precipitation and heparin-Sepharose column chromatography. To obtain preparative amounts of DNA binding proteins for amino
acid sequencing, crude extracts from stationary-phase yeasts were divided into
four fractions by progressive precipitation in 25%, 50%, and 75% ammonium
sulfate; the supernatant fraction from the 75% ammonium sulfate precipitation
served as the fourth fraction. The pellets resulting from the 50% and 75%
ammonium sulfate precipitations as well as the final supernatant fraction were
dialyzed twice against buffer A. Each fraction was loaded onto a 5-ml prepacked
HiTrap heparin-Sepharose column (GE Healthcare, Piscataway, NJ) prior to
stepwise elution with NaCl and analysis by gel mobility shift assays on each
fraction.

Further fractionation using 60% ammonium sulfate was required to identify
Hbp1. The pellet and the supernatant were dialyzed against buffer A, loaded
onto a 5-ml prepacked heparin-Sepharose column, equilibrated with buffer A,
and eluted using a model 2110 fraction collector (Bio-Rad, Hercules, CA) with
a linear NaCl gradient ranging in concentration from 0.02 to 1 M at a flow rate
of 1 ml/1 min. A total of 49 fractions were collected.
Trichloroacetic acid (TCA) was used to precipitate the column fractions by
adding equal volumes of 20% TCA and incubating at 4°C for 30 min. Precipitates
were collected by centrifugation at 13,000 rpm for 15 min, washed with cold
acetone, and dissolved in sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) loading buffer.
(iii) Protein sequencing. Protein fractions showing binding to HCRa were
analyzed by conventional SDS-PAGE using 16% polyacrylamide (22). The Nterminal and internal amino acid sequences of each protein were determined by
the Dartmouth College Molecular Biology Core Facility using either the Edman
method or matrix-assisted laser desorption ionization mass spectrometry
(MALDI-MS) (10).
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(iv) Purification of recombinant proteins from E. coli. Plasmids pSKD703,
pSKD710, pSKD721, and pSKD723 were transformed into E. coli strain
LMG194, in which the araC gene is under the control of the pBAD promoter.
Transformed LMG194 was grown at 37°C to an optical density at 600 nm of 0.5
and then incubated for an additional 3 h with 0.2% L-arabinose to overexpress
the protein of interest. Cells were disrupted by two passages through a French
press (1,000 lb/in2 [1 lb/in2 ⫽ 6.9 kPa]) in binding buffer (50 mM Tris-HCl [pH
8.0], 250 mM NaCl, 5 mM imidazole, 10% glycerol, 0.05% Tween 20, 1 mM
phenylmethylsulfonyl fluoride) and centrifuged at 13,000 rpm for 30 min. The
resultant soluble fraction was applied to a Pro-Bond resin column (Invitrogen,
Carlsbad, CA) and washed with buffer containing 50 mM Tris-HCl (pH 8.0), 125
mM NaCl, 10% glycerol, and 60 mM imidazole. Fusion proteins were eluted with
buffer containing increasing concentrations of imidazole, dialyzed using SnakeSkin pleated dialysis tubing (7,000-molecular-weight cutoff) (Pierce, Rockford,
IL) in EKMax reaction buffer (50 mM Tris-HCl [pH 8.0], 1 mM CaCl2, 0.1%
[vol/vol] Tween 20) overnight, treated with 0.1 U of enterokinase (Invitrogen,
Carlsbad, CA) for 16 h at 37°C to remove thioredoxin, and recovered using
Pro-Bond resin.
(v) Gel mobility shift assays. Gel mobility shift assays were performed as
previously described (17), with modifications. Plasmid pSKD19 was digested with
EcoRI, and 1 g of the resultant HCRa fragment was end labeled with
[␥-33P]ATP by T4 polynucleotide kinase (Invitrogen, Carlsbad, CA). Unlabeled
HCRa and an unrelated DNA fragment from the ENO1 gene were used for
competition assays. A 382-bp segment from ENO1 was obtained by PCR using
primer set ENO2 and pENO1 as a template (39). For the assay, 0.1 ng of labeled
probe was incubated with the indicated amounts of protein from fractions with
200 or 500 ng of sheared salmon sperm DNA (normal conditions) (Ambion,
Austin, TX) or from crude extracts with 3 g of sheared salmon sperm DNA
(high-stringency conditions) (46). The reaction mixtures were loaded onto a
nondenaturing 5% polyacrylamide gel in Tris-borate-EDTA buffer (89 mM Tris
base, 89 mM boric acid, 2 mM EDTA [pH 8.0]) and analyzed by using a Storm
860 PhosphorImager (GE Healthcare, Piscataway, NJ).
Monitoring GFP levels in reporter constructs. Assessment of GFP levels was
performed by using 5 ml of M199 medium prewarmed to 37°C. Over 95% of the
cells in each inoculated culture were observed to produce germ tubes. After germ
tube induction, cells were washed twice with ice-cold phosphate-buffered saline,
resuspended in 100 l phosphate-buffered saline, and transferred into a 96-well
Cytoplate (Applied Biosystems, Foster City, CA). Levels of GFP were measured
by using a Victor2 1420 multilabel counter (Perkin-Elmer, Wellesley, MA) and
normalized by dividing the fluorescence emitted per 1-s exposure by the absorbance seen at an optical density at 600 nm to produce relative fluorescence units.
The fluorescence of each construct was expressed as the percentage of ⫺1902
fluorescence, which was set at 100%. Epifluorescence using a fluorescein isothiocyanate cube with 470 to 490 nm of excitation and 515 to 550 nm of emission
was performed to verify uniform GFP expression throughout the population.
Cells were photographed at ⫻400 magnification with an Olympus (Center Valley, PA) BX60 microscope and MagnaFire S99806 camera and analyzed with
MagnaFire v 2.1 (Optronics, Goleta, CA) and Image-Pro Plus v4.1 (Media
Cybernetics, Silver Spring, MD) software. For each construct, three independent
transformants that had integrated correctly at the ENO1 locus as assessed by
Southern blotting were tested. The variation within transformants was within
20% of the average for their respective constructs. A representative strain was
selected for each construct, and fluorescence values were read in triplicate.

RESULTS
GFP reporter constructs reveal the region at positions
ⴚ1410 to ⴚ1042 (HCR) of the HWP1 promoter to be critical
for activation. To assess whether the previously reported developmentally regulated HWP1 promoter construct placed at
the ENO1 locus (39) in strain HGFP3 contained all of the
regulatory elements associated with the HWP1 promoter, GFP
levels from this strain were compared to those of strain HB-12
containing GFP at the endogenous HWP1 locus (see Materials
and Methods). The fluorescence of HB-12 germ tubes, which
are emerging true hyphae, was clearly increased relative to the
germ tubes of HGFP3, as visualized by fluorescence microscopy, indicating either that pHWP1GFP3 in strain HGFP3 did
not contain the complete set of regulatory elements or that
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integration position effects contribute to HWP1 promoter activation. However, the inclusion of up to 2,025 bp of HWP1
upstream DNA led to levels of fluorescence reaching 90% of
those seen in HB-12, as measured by fluorometry (Fig. 1C).
Other constructs revealed that the addition of DNA from
⫺1840 bp upstream of the transcription start site also conferred near-wild-type levels of activation at the ENO1 locus,
indicating that position effects appeared to play a minor role in
the activation of the HWP1 promoter and that promoter control was retained at the ENO1 locus. Therefore, the ENO1
locus could be used as an integration site for analyses of the
truncated and deleted HWP1 promoter constructs described
below.
To assess the kinetics of HWP1 activation after placement in
germ tube-inducing conditions, GFP expression levels were
measured using fluorometry over time. GFP was detectable in
HB-12 60 min after placing cells in germ tube-inducing conditions and continued to increase over a 7-h period (Fig. 1A). At
each time point, HB-12 showed activation levels that were
higher than those of HGFP3; however, the kinetics of activation were similar for the two strains. Plotting the ratios of
fluorescence at each time point divided by the maximum expression level at 7 h postinduction for both HGFP3 and HB-12
showed that the activation of both strains followed identical
kinetics despite the noteworthy difference in their magnitudes
(Fig. 1B). These results showed that the promoter sequence
upstream of the ⫺1410 region served primarily to amplify the
regulatory effects downstream of position ⫺1410.
A comparison of GFP expression levels in strains with serial
truncations at the 5⬘ end of the HWP1 promoter was performed to identify the regions that were most important for
activation (Fig. 1C). GFP levels were recorded as the percentage of fluorescence observed in the ⫺1902 construct over the
same time period, which was set at 100%. Sequence elements
necessary for the transcriptional activation of the HWP1 promoter spanned a large region, with the most important activating regions being located between positions ⫺1100 and
⫺1840.
The distal activating region extended from positions ⫺1840
to ⫺1410 and contributed approximately 50% of the total
promoter activity compared to position ⫺1902. Incremental
external deletions into the 5⬘ end of the promoter showed a
gradual decline in activation until a sharp drop from 79% to
47% activation of position⫺1902 fluorescence occurred upon
the removal of the 125 bp between positions ⫺1535 and
⫺1410. This decrease was reversed upon the removal of an
additional 44 bp as shown by restoration to 81% of position
⫺1902 fluorescence in the position ⫺1366 construct, indicating
a region conferring repression. Extending the truncations past
position ⫺1366 led to a precipitous decline in fluorescence to
less than 4% of that of position ⫺1902 for constructs with less
than 1,153 bp of promoter sequence.
To further define the interior regions of the HWP1 promoter
that contribute to activation, a series of internal deletion constructs was also tested. Deletion of DNA sequences between
positions ⫺1410 and ⫺1042 in internal deletion strain S diminished promoter activity to 8.8% of that seen in position ⫺1902
(Fig. 1D). Replacement of this region with an equivalent amount
of DNA from the ENO1 coding region in strain SENO1 did not
restore promoter activity (not shown), indicating that HWP1 pro-
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FIG. 1. Analysis of the HWP1 promoter using GFP as a reporter. (A) Time course of GFP expression driven by various promoters including
HWP1 (strain HB-12) (black), ⫺1410 HWP1 (strain HGFP3) (gray), and promoterless (0GFP3) (lined). Fluorescence was quantified according to
the procedures outlined in Materials and Methods. (B) Kinetics of activation of the ⫺1410 region (dotted line) compared to the complete HWP1
promoter (HB-12) (solid line). The values represent the ratios of the fluorescence at each time point relative to the 7-h time point. (C and D)
Dissection of the HWP1 promoter in strains containing external truncations from the 5⬘ end (C) and internal deletions (D). Strains were grown
in M199 medium at 37°C for 2.5 h. Values represent the percent fluorescence of strain ⫺1902, which is indicated by an arrow in C. In D, deleted
DNA is indicated by a dashed line. The arrow indicates the transcription start site, and the diamond just upstream of the arrow signifies a TATA
element. The locations of HCR and HCRa are shown as black bars. Putative NRE and E-box sites are indicated by open circles and black squares,
respectively. (E) Developmental regulation of a heterologous promoter by HCR. HCR alone activated the truncated ENO1 promoter, leading to
GFP expression in germ tubes but not in yeast using strain HCRENO. The diamond represents the TATA box in the ENO1 promoter.

moter activity is dependent largely on the specific sequences
present within the ⫺1410 to ⫺1042 region and is not due simply
to spatial effects. In addition, GFP fluorescence was increased
from 2% to 72.4% when the promoter region between positions
⫺1410 and ⫺1042 was placed adjacent to a truncated construct

with basal levels of activity (position ⫺555) (Fig. 1D, construct E),
indicating that sequences important for HWP1 induction are contained within this region.
The activating ability of the region at positions ⫺1410 to
⫺1042 depended heavily on sequences within 200 bp down-
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stream of position ⫺1410. A construct containing the HWP1
promoter region from positions ⫺1288 to ⫺1042 resulted in an
activation level of only 12.6% when placed adjacent to position
⫺555 (Fig. 1D, construct K2). This result, coupled with a
comparison of the GFP fluorescence exhibited by external
truncations at positions ⫺1410 and ⫺1366, indicate that the
region of the HWP1 promoter between positions ⫺1410 and
⫺1288 contains both activating and repressing activities.
In contrast to the promoter region between positions ⫺1410
and ⫺1042, the more distal region from positions ⫺1902 to
⫺1657 that appeared to confer activation ability in the truncation analysis was not sufficient to activate GFP fluorescence
when placed adjacent to the truncated ⫺555 construct with
basal promoter activity (Fig. 1D, construct M). This result
showed that the region from positions ⫺1902 to ⫺1657 serves
to enhance the activating function of the region between positions ⫺1410 and ⫺1042.
Importantly, the region from positions ⫺1410 to ⫺1042 was
also able to activate a heterologous promoter. Placement of
this region 20 bp upstream of the TATA element of an ENO1
promoter in strain HCRENO led to a fluorescence level of
50% of position ⫺1902 under germ tube-inducing conditions,
a level equivalent to that generated by the ⫺1410 external
deletion (Fig. 1E). The truncated ENO1 promoter by itself
failed to show GFP fluorescence (not shown), indicating that
the sequences between positions ⫺1410 and ⫺1042 are capable of high levels of gene activation in a developmentally regulated fashion independent of other sequences in the HWP1
promoter. Because of its ability to confer hypha-specific regulation of HWP1, the region from positions ⫺1410 to ⫺1042 was
designated the HCR.
The entire HWP1 promoter was analyzed for the presence of
binding sites for Nrg1 and Efg1 (27, 42). A single Efg1 binding
site (E box) from positions ⫺1090 to ⫺1085 and a single Nrg1
binding site (NRE) from positions ⫺1228 to ⫺1223 were found
in HCR. E boxes were found upstream of HCR, which is
suggestive of a possible role for Efg1 in the amplification of the
HWP1 promoter (Fig. 1D). Additional E boxes and NREs were
also found downstream of the activating regions.
The relative levels of activation between the constructs described above were found to depend on the induction of germ
tubes and were not dependent on the media used to induce
germ tubes. However, the absolute level of activation was increased by 2.1-fold by the addition of 10% bovine calf serum
to M199. Under yeast growth conditions, all strains showed
negligible levels of HWP1 promoter activity (not shown).
Pseudohyphal forms did not activate the HWP1 promoter to
the high levels associated with germ tubes but were variably
capable of producing low levels of HWP1 promoter activity
(38).
Identification of proteins from crude extracts binding to the
HCRa promoter region. Given its apparent importance in the
hypha-specific activation of HWP1, it was of interest to identify
DNA binding proteins in crude C. albicans extracts that bound
to the HCR. In addition, we wished to identify differences in
the protein binding patterns in hyphal versus yeast growth
forms at an early time point following hypha induction, when
the mechanisms involved in promoter activation would be in
progress. To this end, extracts were prepared from cells that
had been placed in hypha-inducing conditions for 1 h, a period
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known to be early in the kinetics of activation, when HWP1
mRNA is abundant but not yet at its peak level (3). Crude
extracts were also prepared from comparable cultures incubated at 25°C for 1 h, allowing these cells to retain a yeast
morphology. Crude extracts from stationary-phase yeast cultures were also included to reveal DNA binding proteins
present in the absence of active growth. Henceforth, we refer
to these preparations as hyphal extracts (HE), yeast extracts
(YE), and stationary-phase extracts (STE).
The crude extracts were analyzed by gel mobility shifts. Experiments using the 5⬘ portion of the HWP1 promoter region
extending from positions ⫺1410 to ⫺1162, termed HCRa,
showed the same DNA-protein binding pattern on nondenaturing gels as the original HCR (positions ⫺1410 to ⫺1042)
identified in the promoter deletion analysis (data not shown).
Therefore, HCRa was used in the gel mobility shift experiments described below.
Two major protein-DNA complexes that migrated slower
than free HCRa were detectable in crude extracts from hyphae, yeast, and stationary-phase yeast cells under high-stringency reaction conditions (46) (see Materials and Methods).
The amount of protein binding HCRa was enhanced when
higher amounts of crude extract were used, suggesting a strong
interaction between the two proteins and HCRa. Protein-DNA
complex 2 appeared on the gel initially as two separate bands
(Fig. 2A) of similar molecular weights with additional bands
apparent at higher extract concentrations, suggesting the presence of a single protein with a tendency to multimerize (Fig.
2A, lanes 4, 5, and 6). The intensity of protein-DNA complex
2 appeared to be less in STE at all protein concentrations
compared to those in YE and HE, suggesting that the protein
present in complex 2 has decreased binding activity when the
cells of origin were not actively growing. In contrast, proteinDNA complex 1 was found in HE, YE, and STE as a single
shifted band across all crude extract concentrations. These
results suggested that at least two distinct proteins occupy
HCRa of the HWP1 promoter with distinct binding profiles
that are influenced by growth conditions.
The putative HWP1 promoter binding proteins were specific
in their binding to HCRa. Competition assays (Fig. 2B) revealed that the relative amount of the two protein-HCRa complexes observed in the above-described experiments was
greatly reduced in the presence of a 200- or 50-fold molar
excess of unlabeled HCRa (Fig. 2B, lanes 2 and 3) but not in
the presence of a 200-fold molar excess of ENO1 DNA (Fig.
2B lanes 4). Protein-DNA complex 1 was competed less well by
unlabeled HCRa than protein-DNA complex 2, suggesting that
this complex is stable. The inability of DNA to compete away
either complex was consistent with the low level of activation in
strain SENO1, in which HCR had been replaced with irrelevant ENO1 DNA, and revealed that the putative HCRa binding proteins do not bind DNA in general but are specific in
their interactions with HCRa.
At least four proteins appear to bind HCRa. Crude extracts
were further fractionated with anion-exchange column chromatography followed by gel mobility shift assays under normal
conditions in an attempt to identify proteins that exhibited
differing binding activities in relation to growth conditions. The
protein originally identified in protein-HCRa complex 2 (Fig.
2A) was named Hbp1, (HWP1 control region binding protein
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FIG. 2. Identification of HCRa-protein complexes using crude protein extracts and fractionation by anion-exchange chromatography and gel mobility
shift assays performed on either a 15- by 19-cm vertical gel electrophoresis system (Life Technologies, Gaithersburg, MD) at 200 V for 2 h (A and B)
or a 7- by 10-cm Mini-PROTEAN 3 cell (Bio-Rad, Hercules, CA) at 120 V for 50 min (C to F). (A) Crude extracts (HE, YE, and STE) were mixed with
␥-33P-labeled HCRa in the presence of 3 g sheared salmon sperm DNA (high-stringency reaction conditions). Protein-DNA complexes 1 and 2, as well
as free DNA, are indicated by arrows. Amounts of crude extract used were as follows: lane 1, 0 ng (DNA only); lane 2, 250 ng; lane 3, 500 ng; lane 4,
1,000 ng; lane 5, 3,000 ng; lane 6, 5,000 ng. (B) Competition assay in the presence of unlabeled HCRa and ENO1 DNA. The ␥-33P-labeled fragment was
incubated with 1,000 ng of crude extract from YE and HE and 3,000 ng from STE. Lane D, labeled probe only; lane 1, crude extract only; lanes 2 and
3, 200- and 50-fold molar excesses of unlabeled HCRa, respectively; lane 4, 200-fold molar excess of a region of ENO1 (see Materials and Methods). (C
to F) Fractions prepared from YE and HE containing 25 ng (C and E) or 250 ng (D and F) of protein were mixed with ␥-33P-end-labeled HCRa in the
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1). The number of bands associated with Hbp1 was variable
and depended on the assay conditions. When normal conditions were used with the fractions from ion-exchange chromatography, Hbp1 appeared as a single band (Fig. 2C and E).
Although Hbp1 was present in crude extracts under all
growth conditions, subtle differences were seen in its behavior
between YE and HE. Using the conditions for the crude extracts (Fig. 2C to F, CE lanes), Hbp1 frequently consisted of
three distinct shifted bands in YE (Fig. 2C, CE lane), which is
suggestive of Hbp1 monomers, dimers, and tetramers or multimers in the yeast crude extract, respectively. However, only
two bands were observed in HE, which is suggestive of monomers and dimers (Fig. 2E, CE lane). Under normal conditions,
the mobility of the Hbp1-HCRa complex was retarded at a rate
equivalent to that of the mobility of a possible tetrameric or
multimeric structure of the protein in YE compared to the
putative dimeric or less multimerized form in HE (compare
positions indicated by white arrowheads in Fig. 2C, lanes W
and 5, and E, lanes FT and W, relative to the position of the
bands in lanes labeled CE). Hbp1 also showed different elution
patterns in YE and HE in that DNA binding was detected in
the wash and 0.2 M NaCl fractions from YE (Fig. 2C, lanes W
and 5) and in the flowthrough and wash fractions from HE
(Fig. 2E, lanes FT and W). Even more striking was the finding
that Hbp1 appeared to show a particularly high binding affinity
for HCRa in YE, an observation that was not made with the
original crude extracts using high-stringency conditions. In the
assays using 250 ng of eluted protein, the Hbp1-shifted protein-DNA complex was detectable even in the flowthrough
fraction in YE (Fig. 2D, lane FT). In contrast, fractions containing Hbp1 from HE showed comparatively weak binding
activities (Fig. 2F, lanes FT and W). Together, these results
suggest that Hbp1 may be conformationally altered depending
on environmental stimuli with increased binding activity under
yeast growth conditions.
Protein-HCRa complex 1 from Fig. 2A was detectable in the
flowthrough and wash fractions in both YE and HE; however,
the binding activity of this protein, designated Hbp2, was reduced in YE compared to HE. Gel shifts with only 25 ng
protein clearly showed a complex formed by Hbp2 in the
flowthrough fraction of HE, which was barely detectable in YE
(Fig. 2C and E, lanes FT and W). Using 250 ng of eluted
protein, the entire amount of free DNA was shifted and
formed a polydispersed smear using HE that consisted of aggregates of Hbp2 alone or complexed with other proteins. In
YE, most of the DNA remained unbound, and the shifted band
formed a tight, rapidly migrating complex consistent with reduced binding activity in YE in comparison to HE (Fig. 2D and
F, FT lanes). Overall, this suggested that Hbp2 may be active
specifically under conditions of hyphal growth or may recruit
other proteins during hyphal morphogenesis.
A third protein, named Hbp3, was detected and produced a
shifted band that was slightly smaller than that produced by
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Hbp2 (Fig. 2E, compare the size of the band just above the free
DNA in the FT lane [Hbp2] and lane 5 [Hbp3]) and, unlike
Hbp2, was specifically eluted in the 0.2 M NaCl fraction. Hbp3
is evident in Fig. 2C by the presence of an abundant shifted
band in lane 5, which is diminished in lane 6, that is not formed
in the flowthrough and wash fractions. Even though Hbp3 is
present in reduced amounts in HE, the elution characteristics
are consistent with those from YE. The higher intensity of the
band in lane 5 compared to that in lane W in Fig. 2E is
consistent with optimal elution at 0.2 M NaCl. The increased
abundance in YE is also seen using higher amounts of protein.
Using 250 ng of eluted protein, the entire amount of free DNA
was shifted, forming a polydispersed smear using YE that consisted of aggregates of Hbp3 alone or complexed with other
proteins. By contrast, in HE, most of the DNA remained unbound, and the shifted band formed a tight, rapidly migrating
complex consistent with less binding activity (Fig. 2D and F,
lanes 5).
An additional protein, Hbp4, was detectable in the 400 mM
NaCl fraction using 25 ng of eluted protein from HE (Fig. 2E,
lane 7) but not from YE (Fig. 2C, lane 7). When 250 ng of
eluted protein was used, Hbp4 was detectable in both the 400
and 500 mM NaCl fractions in HE (Fig. 2F, lanes 7 and 8) but
only in the 400 mM NaCl fraction in YE (Fig. 2D, lane 7). In
addition, multimeric forms of Hbp4 were observed in the 400
mM NaCl fraction in HE (Fig. 2F, lane 7). It is important that
the binding activities of Hbp3 and Hbp4 were not confined
exclusively to a single growth form. Although Hbp3 was notably more active in YE compared to HE, it was not completely
absent from the latter. Likewise, Hbp4 was expressed predominantly in HE but was present at low levels in YE as well. We
also observed the presence of protein-DNA complexes that
failed to migrate during electrophoresis located immediately
below the wells in both YE (Fig. 2C, lane 8, and D, lanes 7 and
8) and HE (Fig. 2F, lanes 8 and 9). Taken together, these
results show that HCRa binds several C. albicans proteins and
that their binding activities appear to be strongly influenced by
growth conditions.
Purification and identification of HCRa binding proteins.
To obtain preparative amounts of Hbp1 and Hbp2, crude extracts from stationary-phase cultures were prepared and fractionated by ammonium sulfate precipitation. The proteins of
interest were observed to retain their binding activities in fractions from stepwise ammonium sulfate precipitation (Fig. 3A).
Hbp1 was detectable mainly in the 25% and 50% ammonium
sulfate fractions, whereas Hbp2 was found in all of the ammonium sulfate precipitated fractions as well as in the supernatant
fraction. In subsequent heparin-Sepharose column chromatography from these precipitations, the protein components responsible for the different complexes with HCRa were eluted
with 0.5 M and 1 M NaCl from the 50% and 75% ammonium
sulfate and supernatant fractions (Fig. 3B, C, and D). The
fractions in which protein-DNA complexes could be seen in gel

presence of 200 ng (C and E) or 500 ng (D and F) sheared salmon sperm DNA except for assays in lanes labeled CE, which were performed under
high-stringency conditions as in A and B. The positions of the free DNA and four protein-DNA complexes (Hbp1 to Hbp4) are indicated by arrows.
White arrowheads (C and E) and diamonds (F) represent Hbp1 and Hbp4, respectively. See Results for a complete explanation. Lane D, DNA
only; CE, crude extract; FT, flowthrough; W, wash; lane 5, 0.2 M NaCl; lane 6, 0.3 M; lane 7, 0.4 M; lane 8, 0.5 M; lane 9, 1.0 M.
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FIG. 4. Isolation of Hbp1. STE was precipitated with 60% ammonium sulfate and further fractionated with heparin-Sepharose chromatography
using a 20 to 1,000 mM NaCl gradient. ␥-33P-labeled HCRa (0.1 ng) was mixed with 50 ng of each fraction in the presence of 200 ng sheared salmon
sperm DNA (A) or 250 ng of each fraction in the presence of 500 ng of sheared salmon sperm DNA (B). Lane D contains radiolabeled probe only.
(C) Coomassie blue-stained 16% SDS-polyacrylamide gel to visualize Hbp1 (see arrow and dot next to band) and Hbp5/6. Each lane contained
a 5-g sample from the indicated fraction following TCA precipitation.

mobility shift assays were compared with those fractions that
did not show the presence of DNA binding proteins. A relatively small protein of about 11 kDa was absent from fractions
that did not bind HCRa DNA but was present in other fractions (Fig. 3E, compare lanes 1, 2, 4, 5, 7, and 8 with lanes 3
and 6). A band correlating with Hbp1 binding activity was not
apparent.
In further attempts to identify Hbp1, crude STE was subfractionated by precipitation using 60% ammonium sulfate
followed by column chromatography. The concentration of
ammonium sulfate was chosen based on the presence of
Hbp1 DNA binding activity in the precipitate and because
of the larger amount of protein precipitated compared to
lower ammonium sulfate concentrations in which lower protein yields were obtained (data not shown). Fractions 34 to
40 of this separation contained the highest levels of Hbp1

(Fig. 4A and B) and exhibited the characteristic multimers
exhibited in the CE lanes in Fig. 2C to F. Further analysis
revealed that those fractions that possessed shifted complexes all contained a protein of about 31 kDa (Fig. 4C) that
was present in highest concentration in fraction 34 with
decreasing amounts in subsequent fractions that paralleled
the decrease in binding activity of Hbp1. This protein was
not seen in fractions that were not shifted in previous assays
(data not shown). Although the 31-kDa band was the most
prominent band that was specific to the fractions that produced gel shifts, other bands that migrated faster were also
detected and may also have contributed to complex 2 in
crude extracts (Fig. 2A and B). Identification of these additional bands is in progress. Unexpectedly, the 49th and
final fraction eluted with 1 M NaCl contained a protein that
produced a shifted complex distinct from those seen with

FIG. 3. Fractionation of DNA binding proteins in STE by ammonium sulfate precipitation (A) followed by heparin-Sepharose column
chromatography of each ammonium sulfate fraction (B to D). Gel mobility shift assays were performed in the presence of 500 ng sheared salmon
sperm DNA (A) or with 200 ng sheared salmon sperm DNA using the heparin-Sepharose fractions from stepwise elutions with NaCl from the 50%
(B), 75% (C), and supernatant (D) ammonium sulfate fractions. Lane D, DNA only; lane CE (1,000 ng), crude extract under high-stringency
conditions (see Materials and Methods); FT, flowthrough fraction; W, wash fraction; lanes 2, 3, and 4, 100 ng protein from 50% and 75%
ammonium sulfate saturated fractions and the supernatant fraction, respectively; lanes 11, 12, and 13, 25 ng, 100 ng, and 500 ng protein,
respectively, from the indicated fractions. Fractions that were compared by SDS-PAGE in E are marked with asterisks and diamonds to indicate
the presence of Hbp1 and Hbp2, respectively, and with ovals to indicate fractions that did not show binding activities for either protein. The boxed
numbers correspond to the lane numbers in E that were used for separating the indicated fractions by SDS-PAGE. (E) Silver-stained 16%
SDS-polyacrylamide gel of representative Hbp1- and Hbp2-containing fractions as determined by assays shown in C and D. Each lane contains 1
g of the appropriate fraction. The location of Hbp2 is indicated. The band indicated by the black dot was later found to contain histones (Fig.
4). MW, molecular weight (in thousands).
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TABLE 3. Protein sequence determined by MALDI-MS or N terminal amino acid sequencing

Originally
assigned name

Protein

Amino acidsa

Sequence
coverage (%)

Predicted molecular
mass (kDa)

Hbp1
Hbp2

Gcf1p
Nhp6

15
42

28
11

Hbp5

Htb1

32

14

Hbp6

Hta1

ATKVATTTTKKTTKKAGDSVAEFYOFPEEEKYVQENYIR
MAPGERKKSSRKKKDPDAPKRSLSAYMFFANENRDIVR
AENPGISFGQVGKLLGEKWKALNSEDKLPYENKAEAD
KKRYEKEKAEYAKKNSA
MAPKAEKKPASKAPAEKKPAAKKTATSGTKKRSKTRKET
YSSYIYKVLKQTHPDTGISQKAMSIMNSFVNDIFERIAG
EASKLAAYNKKSTISAREIQTAVRLILPGELAKHAVSEG
TRAVTKYSSAAN
MSGGKGKAGSSEKASTSRSAKAGLTFPVGRVHRLLRKG
NYAQRVGSGAPVYLTSVLEYLAAEILELAGNAARDNK
KSRIIPRHLQLAIRNDEELNKLLGHVTIAQGGVLPNIHQ
NLLPKKSAKGKASQEL

17

14

a

The amino acids determined by sequencing are underlined.

Hbp1 and Hbp2 on nondenaturing gels (Fig. 4A and B,
fraction 49). A band corresponding to a mass of approximately 14 kDa, which was ultimately shown to contain two
proteins (see below), was seen in this fraction (Fig. 4C,
fraction 49). These proteins were named Hbp5 and Hbp6.
Following trypsin digestion and mass spectroscopic analysis,
a peptide from Hbp2 was determined to contain the sequence
APGERKKSSR (Table 3), a sequence which was identical to
the C. albicans nonhistone protein 6 (Nhp6). A BLAST analysis of this sequence revealed that the Nhp6 protein has a
predicted mass of 10,508 Da, which matched the molecular
weight of the band corresponding to Hbp2 in Fig. 3E, and

sequence similarity to Saccharomyces cerevisiae Nhp6A and
Nhp6B, both of which have been shown to bind and bend DNA
(18) and to encode high-mobility-group (HMG)-like proteins
that influence cell and colony morphology (11). The isolated
peptides were subjected to trypsin digestion and found by
MALDI-MS to have 42% cumulative coverage of the Nhp6
protein (Table 3).
N-terminal amino acid sequencing of Hbp1 revealed a sequence of ATKVATTTTK. The sequence of three additional
Hbp1 peptides was determined following trypsin digestion and
mass spectroscopic analysis. The corresponding protein has a
predicted mass of 28,355 Da, which matched the molecular

FIG. 5. Overexpression of recombinant putative HCRa binding proteins. Extracts of strains producing His6-Nhp6 (A), Gcf1p-His6 (B),
Htb1-His6 (C), and Hta1-His6 (D) were analyzed on a Coomassie blue-stained SDS gel. Lane 1, preinduction; lane 2, postinduction; lane 3, soluble
fraction; lane 4, insoluble fraction; lane 5, flowthrough; lane 6, wash; lane 7, 0.1 M imidazole elution; lane 8, 0.2 mM imidazole; lane 9, 0.5 M
imidazole. MW, molecular weight (in thousands).
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FIG. 6. Comparison of recombinant proteins Hbp1, Hbp2, Hbp5, and Hbp6 with proteins from STE to bind to HCRa. (A) Eluate from the 1.0 M
NaCl–75% ammonium sulfate precipitation fraction shown in Fig. 3C compared to purified N-His6-Nhp6. (B) Fraction 34 shown in Fig. 4A to C
compared to purified Gcf1p-His6. (C) Fraction 49 shown in Fig. 4A to C compared to purified Hta1- and Htb1-His6. Protein-HCRa complexes and free
DNA are indicated by arrows. Protein amounts used were as follows: lane 1, 0 ng; lane 2, 2 ng; lane 3, 10 ng; lane 4, 50 ng; lane 5, 250 ng.

weight of the band corresponding to Hbp1 in Fig. 4C, and shows
similarity to an HMG-like protein, Glom, from Physarum
polycephalum, that functions as a mitochondrial DNA condensation factor and is rich in lysine residues (21.7%) (36). Because of the similarities to Glom in amino acid sequence, the
high content of lysine residues (19.0%), and the presence of an
HMG box located near the C terminus, Hbp1 was named
Glom-like condensation factor 1 (Gcf1).
Sequence analysis of Hbp5 and Hbp6 revealed internal peptides with identities to two predicted C. albicans histone proteins, Hta1 and Htb1. The internal peptides showed 17% coverage of Hta1 and 32% coverage of Htb1 (Table 3). Hta1 and
Htb1 have predicted masses of 13,861 Da and 13,988 Da, which
matched their observed masses on SDS-PAGE gels. A BLAST
analysis also revealed a strong similarity to S. cerevisiae histones Hta1 and Htb1, subunits of the nucleosome (29).
Two HMG proteins and histones Htb1 and Hta1 bind to
HCRa at the HWP1 promoter. The genes NHP6, GCF1, HTB1,
and HTA1 were each cloned into plasmid pBAD202/D-TOPO
and transformed into E. coli strain LMG194 to facilitate the
overexpression of fusions between the C. albicans proteins and
thioredoxin and His6 tags following induction with 0.2% Larabinose (see Materials and Methods). Major bands with mo-

bilities of 25 kDa (Nhp6), 45 kDa (Gcf1p), and 28 kDa (Hta1
and Htb1), which were the expected sizes of each fusion protein of interest when factoring in the 11.7-kDa thioredoxin and
2-kDa His6 tags, were found in crude extracts from E. coli
LMG194 induced with arabinose and carrying the appropriate
plasmids (Fig. 5). These results indicated that the overproduced proteins were the expected fusion proteins of interest.
The purified His6-Nhp6, Gcf1p-His6, Htb1-His6, and Hta1His6 proteins were tested for their ability to bind HCRa by gel
mobility shift assays. The fusion proteins bound efficiently to
the DNA fragment carrying HCRa and showed increased binding abilities upon increasing the protein concentration (Fig. 6).
Gel mobility shift assays using the recombinant proteins mirrored those seen using extracts from stationary-phase C. albicans cells containing the corresponding endogenous proteins,
especially for the most rapidly migrating shifted bands, which
are indicative of monomeric protein-DNA complexes. The differing appearances of shifted bands formed by the recombinant proteins and the proteins in STE (Fig. 6B and C, compare
lane 5 in each) are most likely the result of the presence of
additional unidentified proteins in STE that influence the multimerization properties of the proteins in the shifted bands.
Competition experiments similar to those shown in Fig. 2B
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FIG. 7. Competition assay in the presence of 50- and 200-fold molar excesses of unlabeled DNA fragments from HCR and ENO1. Recombinant
proteins (100 ng) His6-Nhp6 (A) and Gcf1p-His6 (B) were incubated with ␥-33P-labeled subregions of HCRa designated HCRa1 and HCRa2
(positions ⫺1410 to ⫺1249 and positions ⫺1322 to ⫺1162, respectively) or with a 160-bp region of ENO1 (positions ⫹1250 to ⫹1405) in the
presence of 1,000 ng salmon sperm DNA. Lane D, probe only; lane 1, protein only; lanes 2 and 4, 50- and 200-fold unlabeled DNA from HCR;
lanes 3 and 5, 50- and 200-fold ENO1 DNA.

using His6-Nhp6, and Gcf1p-His6 showed that, like the proteins in native extracts, the recombinant proteins were not
competed away by irrelevant DNA (Fig. 7).
DISCUSSION
The regulation of morphology-specific gene expression is a
poorly understood process that is critical for the ability of C.
albicans to adapt to and invade human hosts. The findings in
this work have identified an unusually long HWP1 promoter
and have elucidated a critical cis-acting region, HCR, which
independently confers developmental regulation to a heterologous promoter. The discovery of a highly conserved protein,
Nhp6, as well as a novel architectural HMG protein, Gcf1p,
that bind specifically to this region suggests that chromatin
structure may play a key role in the developmental regulation
of hypha-specific genes. These findings are in agreement with
work from other laboratories showing that that the Swi/Snf
complex is required for HWP1 gene expression and morphogenesis (26) and that histone modification is important for
normal morphogenesis (33).
The activity of the HWP1 promoter for external deletion
constructs between positions ⫺1410 and ⫺1042 correlated
roughly with length and did not appear to be dependent on
discrete activation motifs that typically form the basis of regulatory elements. Instead, a centrally located 368-bp critical
region, HCR, was found, which conferred developmental regulation independently of other HWP1 promoter DNA and was
characterized by having both activating and repressing activities located in close proximity to each other. Deletions into the
5⬘ end of HCR resulted in the loss of activating properties,
whereas internal deletions into the 3⬘ region showed mixed
results (not shown). The activating ability of HCR might have
been enhanced if additional 5⬘ sequences had been included
based on the decreased activity of the ⫺1410 external deletion
construct relative to position ⫺1535; however, the sequences

between positions ⫺1535 and ⫺1410 were not critical for developmental regulation. HCR contained both activating and
repressing activities and resisted attempts to isolate separable
segments responsible for each type of activity. In keeping with
the close relationship between the repressing and activating
activities of HCR was the inability of any of the mapping
constructs to activate the promoter during growth in yeastinducing conditions. Thus, the mechanisms of repression and
activation appeared to be intertwined within this sequence.
Activation conferred by HCR did not reach wild-type levels
but was amplified by a distal region of the promoter that was
not able to confer developmental expression on its own. The
regions downstream of position ⫺1042, in contrast, showed
minimal activating function and appeared to be dispensable
based on the independent functioning of HCR in the developmental regulation of a chimeric promoter.
The identities of the proteins that bound HCR from crude
extracts strongly implicate chromatin structure in the activation of the HWP1 gene. Nhp6 contains a single HMG box
domain that is responsible for DNA binding (http://smart.embl
-heidelberg.de) and belongs to the HMG1 subfamily of HMG
proteins (9) that bind to DNA in either a sequence-specific or
-nonspecific fashion (44). Nhp6 was found to specifically bind
to the HCRa region in YE, HE, and STE under conditions of
high stringency. Although both native Nhp6 and recombinant
Nhp6 were selective for HCRa in competition assays using
control DNA under conditions of high stringency, Nhp6 did
not protect specific DNA sites in HCRa from DNase I cleavage
as seen on urea-denaturing gels (data not shown). These findings are consistent with a high affinity of binding of Nhp6 to
HCRa that is characteristic of this class of HMG proteins (44).
Nhp6 was also present in extracts from 2-h hyphae, 2-h yeast,
and stationary-phase cells, confirming its continued presence
during hyphal growth beyond the 1-h time point used in the
data reported herein (data not shown).
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FIG. 8. Proposed model for the developmental regulation of the HWP1 gene. (A) Under yeast growth conditions, tightly compacted DNAhistone octamers (white disks, H2A/H2B; gray disks, H3/H4) and relatively strong binding of Gcf1p (Hbp1) (circles) and Hbp3 (squares) to the
HCR region inhibit occupation of DNA by activators. (B) Under germ tube-inducing conditions, a putative cFACT containing Nhp6 (oval)
functions in facilitating the removal of ubiquitinized H2A and/or H2B (dotted disk) and relaxes DNA on nucleosomes, thereby permitting an
enhancer (Hbp4) (triangles) to gain access to the promoter region to activate the HWP1 gene. The location of HCR (positions ⫺1410 to ⫺1042)
is indicated on the top of each model.

The identification of an HMG-like HCRa binding protein,
Gcf1p, which has a domain showing weak similarity (30%) to a
P. polycephalum protein nicknamed Glom because of its function in the compact condensation of mitochondrial DNA (36),
provided further support for the influence of chromatin structure in HWP1 promoter regulation. Gcf1p showed higher binding activity in yeast cultures than in hyphal cultures and appeared to show conformational changes between yeast and
hyphal growth conditions. The increased presence of Gcf1p in
yeast might reflect its contribution to repressing HWP1 promoter activation in yeast (see below), although this function
requires further investigation.
The identification of histones in HCRa binding is consistent
with the relative ease of reconstitution of mononucleosomes in
vitro with purified core histones and DNA fragments that
range from about 150 bp to 250 bp in length (24). Also consistent with this, the 49th fraction prepared using heparinSepharose column chromatography and the 60% ammonium
sulfate precipitation formed a complex with the 249-bp HCRa
fragment on nondenaturing gels that turned out to contain two
histones indicative of an H2A/H2B dimer (Table 3).
Potential interactions between H2A/H2B and Nhp6, as suggested by their coelution in the same column fraction (Fig. 3E),
and the increased activity of Nhp6 in HE (Fig. 2) prompt a
partial model for HWP1 promoter activation based on the role
of S. cerevisiae Nhp6 in chromatin reorganization and in tran-

scriptional initiation and elongation (5, 13) (Fig. 8). Of particular interest is a transcription elongation factor called FACT
(facilitates chromatin transcription), which restructures chromatin in the absence of ATP hydrolysis (34). In S. cerevisiae,
the FACT complex consists of Spt16/Cdc68, Pob3, and Nhp6
and functions in histone degradation, the initiation of transcription (13, 25, 35, 45), and the promotion of TATA binding
protein binding to a TATA box in chromatin both in vivo and
in vitro (5). Proteins with 50 and 55% identities to S. cerevisiae
Spt16 and Pob3 are present in the C. albicans SC5314 genome.
In HeLa cells, FACT binds to nucleosomes following the
monoubiquitination of lysine residue 120 of histone H2B and
facilitates the removal of H2A/H2B and, ultimately, the separation of DNA from the nucleosome (32).
NHP6 mRNA was detected equally in both yeast and hyphal
cells by reverse transcription-PCR (data not shown), arguing
against increased NHP6 expression being responsible for the
enhanced activity of Nhp6 in gel mobility shifts using HE.
Although the reasons for increased activity in hyphal extracts
are unknown, one possibility is that preferred interactions with
the H2A/H2B dimer in hyphae based on putative hypha-specific posttranslational modifications at their respective C termini would contribute to Nhp6’s enhanced binding activity in
HE if Nhp6 is indeed a subunit of a putative C. albicans FACT
(cFACT) complex. cFACT-histone interactions may relax
chromatin in the promoter region during activation. The pres-
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ence and function of a cFACT complex are potentially fruitful
areas of investigation for understanding HWP1 promoter regulation.
Our characterization of HCRa binding proteins has provided insight into the complex nature of repressing and activating functions at the HWP1 promoter that became evident
from our GFP reporter studies. One possible scenario for the
regulatory functions of these DNA binding proteins is that
Gcf1p (Hbp1) and Hbp3, which show higher binding activities
in YE, act as repressors of HWP1 transcription, whereas Nhp6
(Hbp2) and Hbp4, which have increased activities in HE, act as
activators. The lesser activities of Gcf1p and Hbp3 in HE and
Nhp6 and Hbp4 in YE are suggestive of a model of competition between these proteins for binding to HCRa that is dependent on growth conditions to determine which HCRa binding factors are expressed in their activated forms at levels
favoring successful binding to the promoter.
Further support for the idea that the HWP1 promoter is
regulated in a growth condition-dependent manner by repressing and/or activating factors at HCRa is shown by the observation that Hbp3 and Nhp6 (Hbp2) were found to bind near
the 5⬘ end of HCRa between positions ⫺1410 and ⫺1289,
whereas Gcf1p and Hbp4 formed protein-DNA complexes
closer to the 3⬘ end between positions ⫺1365 and ⫺1162 (data
not shown). It is possible that under yeast growth conditions,
multimeric forms of Gcf1p interact with HCRa along with
Hbp3, thereby impeding Nhp6 and Hbp4 from binding and
imposing repression. In support of this model, we found that
under germ tube-inducing conditions, Gcf1p appeared to be
less multimerized, possibly as a result of conformational
changes or loss or gain of posttranslational modifications, and
Hbp3 showed reduced binding activity, potentially because of
reduced expression. This shift in expression patterns would
allow Nhp6 or Nhp6-interacting proteins and Hbp4 to gain
access to HCR and enhance HWP1 expression. Since the binding of Hbp3 and Nhp6 as well as that of Gcf1p and Hbp4
potentially overlap, competition for binding in HCRa that
would be dependent on growth conditions would be expected
to occur.
Several conclusions regarding the HWP1 promoter are in
agreement with those of Brown and coworkers, who studied
the developmentally regulated ALS3 gene. The spatial pattern
of a critical region capable of conferring developmental regulation and a distal region that amplified the effect of this critical
region was found for both promoters, although these elements
were much closer to the coding region in the case of the ALS3
promoter. The relationship between the distal and proximal
regions in terms of the former enhancing the latter was verified
by kinetic studies for both promoters, and the critical regions
were both longer than would be predicted based on standard
transcription factor binding motifs. Attempts to further delimit
the critical regions, 150 bp for ALS3 and 368 bp for HWP1,
were not fruitful in either study. Subtle differences between the
two promoters were also noted. The HWP1 promoter appeared to activate GFP expression to higher levels, and the
period of activation was extended well past the 1-h peak shown
for the ALS3 promoter.
For both the ALS3 and HWP1 promoters, the critical activating regions were notable for the paucity of morphogenetic
transcription factor binding sites for known regulators such as
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Efg1, Tec1, Cph1, and Cph2. Consistent with its role in the
activation of the ALS3 promoter, as shown using a bcr1⌬/bcr1⌬
mutant (30), Bcr1 also functioned in the activation of the
HWP1 promoter, although the HWP1 promoter retained 37%
activating activity relative to HB-12 in the bcr1⌬/bcr1⌬ mutant
background (not shown).
Activating regions from both promoters showed evidence of
sites for repressor activity located in close proximity. Besides
the potential for repression mediated by chromatin-condensing activities described above, strong evidence for the function
of Nrg1 was found. A single binding site for Nrg1 was found in
the critical activation regions of both the ALS3 and HWP1
promoters. Increased activation of both promoters (not shown
for HWP1) was found in yeast growth conditions using nrg1⌬/
nrg1⌬ and tup1⌬/tup1⌬ null mutants. Although Nrg1 was not
among the four proteins identified from crude extracts of C.
albicans that bound to HCRa, it may be one of the unidentified
factors that was observed in gel mobility shift experiments.
Overall, both studies supported the assertion that hypha-specific promoters are complex and are likely to be regulated by
multiple factors.
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